دورية أكاديمية
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
| العنوان: | Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 |
|---|---|
| المؤلفون: | Kim, M., Lee, J.L., Shin, S.J., Bae, W.K., Lee, H.J., Byun, J.H., Choi, Y.J., Youk, J., Ock, C.Y., Kim, S., Song, H., Park, K.H., Keam, B. |
| المصدر: | In ESMO Open August 2023 8(4) |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 20597029 |
|---|---|
| DOI: | 10.1016/j.esmoop.2023.101588 |